期刊文献+

猪胆汁性肝硬化模型的造模及评价与分析

Evaluation and Analysis Model of Biliary Cirrhosis of Porcine
下载PDF
导出
摘要 目的探讨手术结扎总胆管制备胆汁性肝硬化模型的成功率,寻求评估肝储备功能、肝硬化程度的方法。方法选择普通猪10头,剖腹、游离结扎胆总管,定期取材采样进行相关检测、测量门静脉压。结果4头猪分别于第3、45、周死亡,肝硬化模型死亡率为40%,肝硬化形成率100%,用药早期,ALT、AST呈逐渐上升趋势,后期ALT、AST趋于平稳,并有下降的趋势,总胆红素持续上升;白蛋白持续下降。结论肝硬化模型成功率较高,造模时间短,但死亡率较高,病理活检仍是目前确诊肝纤维化的金标准,ALT、AST变化对于评价肝硬化的发展无意义;白蛋白、总胆红素水平在肝硬化形成不同阶段具有统计学差异,对于评价肝硬化进程具有一定的价值,但灵敏性较低,积极寻求对肝硬化进展程度评估价值较高指标是今后努力的目标。 Objective To discuss achievement ratio and mortality rate of preparation of porcine model of biliary cirrhosis, and seek methods to evaluate hepatic function reserve. Methods Choosing ten common pigs as experimental animal, cutting the belly open, dissociating and ligating common bile duct, during the course of the experimental procedure, we collect samples and measure portal venous pressure regularly. Results The rate of success is 100 percent and the rate of mortality is 40 per cent. ALT and AST go up step by step in the early stages, then go steady. TBIL increases continuously, on the contrary, albumin decreases continuously. Conclusion Rate of success of model of hepatic cirrhosis is more higher and time which is needed is shorter, but the rate of mortality is more higher. Pathology biopsy is still a gold standard of diagnosing fibrosis at present. The changes of ALT and AST have no significance for evaluating the development of hepatic cirrhosis. Albumin and bilirubin have obviously difference in before- and after-liver cirrhosis, which is useful to evaluate liver cirrhosis, but sensibility is poor, we should take active in seeking more valuable indexes.
出处 《中国比较医学杂志》 CAS 2007年第9期516-518,559,共4页 Chinese Journal of Comparative Medicine
基金 内蒙古医学院重大课题基金资助(NY2003ZD001)
关键词 胆汁性肝硬化模型 Pig Model of biliary cirrhosis
  • 相关文献

参考文献4

二级参考文献14

  • 1史留斌,彭承宏,彭淑牖,刘颖斌,何伟,徐斌,陈晓鹏,白明东,王涌,唐则.原位辅助性部分肝移植治疗门静脉高压症的实验研究[J].中国危重病急救医学,2004,16(12):730-733. 被引量:6
  • 2吕明德,黄洁夫.腹腔注射四氯化碳配合营养控制制备犬肝硬化模型[J].中华实验外科杂志,1993,10(2):56-57. 被引量:18
  • 3Terpstra O T,Schalm S W,Weimar W,et al.Auxiliary partial liver transplantation for end-stage chronic liver disease[J].N Engl J Med,1988,319:1507-1511.
  • 4Rinkes I H,Hoop G V D,Hesselink E J,et al.Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension[J]? Gastroenterology,1991,100:1126-1128.
  • 5Broelsch C E,Emond J C,Whitington P F,et al.Application of reduced-size liver transplants as split grafts,auxiliary orthotopic grafts,and living related segmental transplants[J].Ann Surg,1990,212:368-377.
  • 6Kaibori M,Egawa H,Inomata Y,et al.Selective portal blood flow diversion in auxiliary partial orthotopic liver transplantation to induce regeneration of the graft[J].Transplantation,1998,66:935-937.
  • 7Ikegami T,Nishizaki T,Yanaga K,et al.Living-related auxiliary partial orthotopic liver transplantation for primary sclerosing chonangitis-subsequent removal of the native liver[J].Hepatogastroenterology,1999,46:2951-2954.
  • 8Rela M,Muiesan P,Vilca-Melendez H,et al.Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I[J].Ann Surg,1999,229:565-569.
  • 9石寅皓,孙士其.吲哚青绿滞留率测定及其对肝硬化的诊断价值[J].陕西医学检验,1998,13(2):20-21. 被引量:4
  • 10金树根.二甲基亚硝胺致实验性肝损伤的研究概况[J].中西医结合肝病杂志,1993,3(1):49-51. 被引量:11

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部